• Issue

    American Journal of Hematology: Volume 93, Issue 2

    155-316, E33-E57
    February 2018
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION – TABLE OF CONTENTS

Free Access

ISSUE INFORMATION – TABLE OF CONTENTS

  • Pages: 155-157
  • First Published: 08 January 2018

RESEARCH ARTICLES

Free Access

A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)

Paula Tanabe,  Susan Silva,  Hayden B. Bosworth,  Regina Crawford,  Judith A. Paice,  Lynne D. Richardson,  Christopher N. Miller,  Jeffrey Glassberg, 
  • Pages: 159-168
  • First Published: 19 October 2017
Free Access

Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation

Andrew L. Gilman,  Wing Leung,  Morton J. Cowan,  Mark Cannon,  Stacy Epstein,  Carrie Barnhart,  Krishna Shah,  Michelle Hyland,  Tracy Fukes,  Anastasia Ivanova, 
  • Pages: 169-178
  • First Published: 19 October 2017
Free Access

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

Arjun Lakshman,  Preet Paul Singh,  S. Vincent Rajkumar,  Angela Dispenzieri,  Martha Q. Lacy,  Morie A. Gertz,  Francis K. Buadi,  David Dingli,  Yi Lisa Hwa,  Amie L. Fonder,  Miriam Hobbs,  Suzanne R. Hayman,  Steven R. Zeldenrust,  John A. Lust,  Stephen J. Russell,  Nelson Leung,  Prashant Kapoor,  Ronald S. Go,  Yi Lin,  Wilson I. Gonsalves,  Taxiarchis Kourelis,  Rahma Warsame,  Robert A. Kyle,  Shaji K. Kumar, 
  • Pages: 179-186
  • First Published: 25 October 2017
Free Access

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

Jithma P. Abeykoon,  Jonas Paludo,  Rebecca L. King,  Stephen M. Ansell,  Morie A. Gertz,  Betsy R. LaPlant,  Alese E. Halvorson,  Wilson I. Gonsalves,  David Dingli,  Hong Fang,  S. Vincent Rajkumar,  Martha Q. Lacy,  Rong He,  Taxiarchis Kourelis,  Craig B. Reeder,  Anne J. Novak,  Ellen D. McPhail,  David S. Viswanatha,  Thomas E. Witzig,  Ronald S. Go,  Thomas M. Habermann,  Francis K. Buadi,  Angela Dispenzieri,  Nelson Leung,  Yi Lin,  Carrie A. Thompson,  Suzanne R. Hayman,  Robert A. Kyle,  Shaji K. Kumar,  Prashant Kapoor, 
  • Pages: 187-194
  • First Published: 28 October 2017
Free Access

Mutations of the integrin αIIb/β3 intracytoplasmic salt bridge cause macrothrombocytopenia and enlarged platelet α-granules

Marie Favier,  Jean-Claude Bordet,  Remi Favier,  Vasiliki Gkalea,  Xavier Pillois,  Philippe Rameau,  Najet Debili,  Marie-Christine Alessi,  Paquita Nurden,  Hana Raslova,  Alan Nurden, 
  • Pages: 195-204
  • First Published: 01 November 2017
Open Access

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)

Ari Zimran,  Nadia Belmatoug,  Bruno Bembi,  Patrick Deegan,  Deborah Elstein,  Diego Fernandez-Sasso,  Pilar Giraldo,  Ozlem Goker-Alpan,  Heather Lau,  Elena Lukina,  Zoya Panahloo,  Ida Vanessa D. Schwartz,  on behalf of the GOS Study group , 
  • Pages: 205-212
  • First Published: 01 November 2017
Open Access

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

Jessica K. Altman,  James M. Foran,  Keith W. Pratz,  Denise Trone,  Jorge E. Cortes,  Martin S. Tallman, 
  • Pages: 213-221
  • First Published: 15 November 2017
Open Access

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

Brenda M. Sandmaier,  Samer Khaled,  Betül Oran,  Guy Gammon,  Denise Trone,  Olga Frankfurt, 
  • Pages: 222-231
  • First Published: 01 November 2017
Free Access

Outgrowing the laboratory diagnosis of type 1 von Willebrand disease: A two decade study

Mouhamed Yazan Abou-Ismail,  Gbolahan O. Ogunbayo,  Michelle Secic,  Peter A. Kouides, 
  • Pages: 232-237
  • First Published: 03 November 2017
Free Access

Excess mortality among 10-year survivors of classical Hodgkin lymphoma in adolescents and young adults

Ana C. Xavier,  Narendranath Epperla,  Jeffrey W. Taub,  Luciano J. Costa, 
  • Pages: 238-245
  • First Published: 08 November 2017
Free Access

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

Jonathan Canaani,  Bipin N. Savani,  Myriam Labopin,  Xiao-Jun Huang,  Fabio Ciceri,  William Arcese,  Yener Koc,  Johanna Tischer,  Didier Blaise,  Zafer Gülbas,  Maria Teresa Van Lint,  Benedetto Bruno,  Mohamad Mohty,  Arnon Nagler, 
  • Pages: 246-253
  • First Published: 08 November 2017
Free Access

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

Daniel J. DeAngelo,  Andrew M. Brunner,  Lillian Werner,  David Avigan,  Amir T. Fathi,  Adam S. Sperling,  Abigail Washington,  Dina Stroopinsky,  Jacalyn Rosenblatt,  Malgorzata McMasters,  Katarina Luptakova,  Martha Wadleigh,  David P. Steensma,  Gabriela S. Hobbs,  Eyal C. Attar,  Philip C. Amrein,  Benjamin L. Ebert,  Richard M. Stone,  Karen K. Ballen, 
  • Pages: 254-261
  • First Published: 09 November 2017
Free Access

Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial

Mohsen Saleh Elalfy,  Amira Adly,  Hanem Awad,  Mohamed Tarif Salam,  Vasilios Berdoukas,  Fernando Tricta, 
  • Pages: 262-268
  • First Published: 09 November 2017
Free Access

A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target

Mathilde Gavillet,  Kimberly Martinod,  Raffaele Renella,  Denisa D. Wagner,  David A. Williams, 
  • Pages: 269-276
  • First Published: 10 November 2017
Free Access

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms

Rita Assi,  Hagop M. Kantarjian,  Guillermo Garcia-Manero,  Jorge E. Cortes,  Naveen Pemmaraju,  Xuemei Wang,  Graciela Nogueras-Gonzalez,  Elias Jabbour,  Prithviraj Bose,  Tapan Kadia,  Courtney D. Dinardo,  Keyur Patel,  Carlos Bueso-Ramos,  Lingsha Zhou,  Sherry Pierce,  Romany Gergis,  Carla Tuttle,  Gautam Borthakur,  Zeev Estrov,  Rajyalakshmi Luthra,  Juliana Hidalgo-Lopez,  Srdan Verstovsek,  Naval Daver, 
  • Pages: 277-285
  • First Published: 14 November 2017

CRITICAL REVIEW

Free Access

Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults

Riad El Fakih,  Elias Jabbour,  Farhad Ravandi,  Mona Hassanein,  Farhan Anjum,  Syed Ahmed,  Hagop Kantarjian, 
  • Pages: 286-295
  • First Published: 03 October 2017

ANNUAL CLINICAL UPDATES IN HEMATOLOGICAL MALIGNANCIES

Free Access

Follicular lymphoma: 2018 update on diagnosis and management

Arnold Freedman, 
  • Pages: 296-305
  • First Published: 08 January 2018

CLINICAL PEARLS IN BLOOD DISEASES

MORPHOLOGY UPDATE

Free Access

Marked leukemoid reaction in a patient with metastatic breast carcinoma

Yasmin Harvey,  Shane Bleakley,  Piers Blombery,  Barbara J. Bain, 
  • Pages: 306-307
  • First Published: 11 July 2017

TEST OF THE MONTH

Free Access

Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?

Emmanuel J. Favaloro, 
  • Pages: 308-314
  • First Published: 22 November 2017

IMAGES IN HEMATOLOGY

Free Access

Not bitten by the bug: A CD30+ lymphoproliferative disorder masquerading as arthropod bites

Jacqueline McKesey,  Travis Vandergriff,  Heather Wickless, 
  • Pages: 315-316
  • First Published: 11 July 2017

E-ONLY ARTICLES

CORRESPONDENCE

Free Access

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis

Paola Minetto,  Fabio Guolo,  Marino Clavio,  Annalisa Kunkl,  Nicoletta Colombo,  Enrico Carminati,  Livia Giannoni,  Filippo Ballerini,  Roberto Massimo Lemoli,  Marco Gobbi,  Maurizio Miglino, 
  • Pages: E33-E35
  • First Published: 28 October 2017
Free Access

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases

Massimo Gentile,  Tait D. Shanafelt,  Francesca R. Mauro,  Luca Laurenti,  Davide Rossi,  Stefano Molica,  Iolanda Vincelli,  Giovanna Cutrona,  Giuseppina Uccello,  Sara Pepe,  Ernesto Vigna,  Giovanni Tripepi,  Kari G. Chaffee,  Sameer A. Parikh,  Sabrina Bossio,  Anna Grazia Recchia,  Idanna Innocenti,  Raffaella Pasquale,  Antonino Neri,  Manlio Ferrarini,  Gianluca Gaidano,  Robin Foà,  Fortunato Morabito, 
  • Pages: E35-E37
  • First Published: 03 November 2017
Free Access

A descriptive study of the characteristics of older adults with sickle cell disease

Anjum B. Khan,  Rachel Kesse-Adu,  Cormac Breen,  Patrick B. Murphy,  John Chambers,  Paul Holmes,  Joanna Howard, 
  • Pages: E38-E40
  • First Published: 03 November 2017
Free Access

Hispanic ethnicity as a risk factor for requiring glucarpidase rescue in pediatric patients receiving high-dose methotrexate

Eric S. Schafer,  M. Brooke Bernhardt,  Kate E. Reichert,  Tara E. Haworth,  Mona D. Shah, 
  • Pages: E40-E42
  • First Published: 09 November 2017
Free Access

The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding

Mohammed Almakadi,  Christopher Sheasgreen,  Ahmed Barefah,  Lucy Lu,  Nidhi Kumar Tyagi,  Gillian Mazzetti,  Lindsay Crabbe,  Yuhong Yuan,  Mark Crowther,  Grigorios Leontiadis, 
  • Pages: E42-E45
  • First Published: 09 November 2017
Free Access

Identification of ceruloplasmin as a biomarker of chronic kidney disease in urine of sickle cell disease patients by proteomic analysis

Marina Jerebtsova,  Santosh L. Saraf,  Xionghao Lin,  Gillian Lee,  Elena Afia Adjei,  Namita Kumari,  Nowah Afangbedji,  Rasha Raslan,  Charlee McLean,  Victor R. Gordeuk,  Sergei Nekhai, 
  • Pages: E45-E47
  • First Published: 10 November 2017
Free Access

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad,  Patrick Hoversten,  Candace L. Haddox,  Kamila Cisak,  Jonas Paludo,  Ayalew Tefferi, 
  • Pages: E47-E49
  • First Published: 14 November 2017
Free Access

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia

Roland B. Walter,  Laura C. Michaelis,  Megan Othus,  Geoffrey L. Uy,  Jerald P. Radich,  Richard F. Little,  Sandi Hita,  Lalit Saini,  James M. Foran,  Aaron T. Gerds,  Heidi D. Klepin,  Annette E. Hay,  Sarit Assouline,  Jeffrey E. Lancet,  Stephen Couban,  Mark R. Litzow,  Richard M. Stone,  Harry P. Erba, 
  • Pages: E49-E52
  • First Published: 22 November 2017
Free Access

Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)

Sophie Godet,  Caroline Protin,  Jehan Dupuis,  Caroline Dartigeas,  Jean-Noël Bastie,  Charles Herbaux,  Véronique Leblond,  Sophie de Guibert,  David Ghez,  Annie Brion,  Loïc Ysebaert,  Alain Delmer,  Anne Quinquenel, 
  • Pages: E52-E54
  • First Published: 22 November 2017
Free Access

Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)

Erika Borlenghi,  Chiara Pagani,  Patrizia Zappasodi,  Massimo Bernardi,  Claudia Basilico,  Elisabetta Todisco,  Nicola Fracchiolla,  Valentina Mancini,  Mauro Turrini,  Matteo Da Vià,  Elisa Sala,  Chiara Cattaneo,  Marta Petullà,  Federico Serana,  Andrea Ferrario,  Roberto Cairoli,  Agostino Cortelezzi,  Armando Santoro,  Carlo Castagnola,  Giuseppe Rossi, 
  • Pages: E54-E57
  • First Published: 22 November 2017